155 related articles for article (PubMed ID: 14707767)
1. Targeting the immune system to improve ventilatory function in muscular dystrophy.
Gosselin LE; McCormick KM
Med Sci Sports Exerc; 2004 Jan; 36(1):44-51. PubMed ID: 14707767
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage.
Gehrig SM; Ryall JG; Schertzer JD; Lynch GS
Exp Physiol; 2008 Nov; 93(11):1190-8. PubMed ID: 18567600
[TBL] [Abstract][Full Text] [Related]
3. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion.
Gosselin LE; Barkley JE; Spencer MJ; McCormick KM; Farkas GA
Muscle Nerve; 2003 Sep; 28(3):336-43. PubMed ID: 12929194
[TBL] [Abstract][Full Text] [Related]
4. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
Hodgetts S; Radley H; Davies M; Grounds MD
Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
[TBL] [Abstract][Full Text] [Related]
5. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice.
Piers AT; Lavin T; Radley-Crabb HG; Bakker AJ; Grounds MD; Pinniger GJ
Neuromuscul Disord; 2011 Feb; 21(2):132-41. PubMed ID: 21055937
[TBL] [Abstract][Full Text] [Related]
6. Mdx respiratory impairment following fibrosis of the diaphragm.
Ishizaki M; Suga T; Kimura E; Shiota T; Kawano R; Uchida Y; Uchino K; Yamashita S; Maeda Y; Uchino M
Neuromuscul Disord; 2008 Apr; 18(4):342-8. PubMed ID: 18358722
[TBL] [Abstract][Full Text] [Related]
7. A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of pirfenidone.
Gosselin LE; Williams JE; Personius K; Farkas GA
Muscle Nerve; 2007 Feb; 35(2):208-16. PubMed ID: 17058274
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy.
Andreetta F; Bernasconi P; Baggi F; Ferro P; Oliva L; Arnoldi E; Cornelio F; Mantegazza R; Confalonieri P
J Neuroimmunol; 2006 Jun; 175(1-2):77-86. PubMed ID: 16647144
[TBL] [Abstract][Full Text] [Related]
10. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle.
Gosselin LE; Williams JE; Deering M; Brazeau D; Koury S; Martinez DA
Muscle Nerve; 2004 Nov; 30(5):645-53. PubMed ID: 15389721
[TBL] [Abstract][Full Text] [Related]
11. [Effect of long-term administration of prednisolone on serum creatine kinase and muscle pathology of mdx mouse].
Takagi A; Watanabe T; Kojima S; Endo Y
Rinsho Shinkeigaku; 1998 Aug; 38(8):724-8. PubMed ID: 9916517
[TBL] [Abstract][Full Text] [Related]
12. Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort.
Archer JD; Vargas CC; Anderson JE
FASEB J; 2006 Apr; 20(6):738-40. PubMed ID: 16464957
[TBL] [Abstract][Full Text] [Related]
13. Mild dystrophic damage in the androgen-sensitive levator ani muscle of the mdx mouse.
Souccar C; Gonçalo Mdo C; Buck Hde S; Lima-Landman MT; Lapa AJ
Neuromuscul Disord; 2005 Jan; 15(1):48-56. PubMed ID: 15639121
[TBL] [Abstract][Full Text] [Related]
14. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
Radley HG; Davies MJ; Grounds MD
Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
[TBL] [Abstract][Full Text] [Related]
15. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy.
Morales MG; Cabello-Verrugio C; Santander C; Cabrera D; Goldschmeding R; Brandan E
J Pathol; 2011 Dec; 225(4):490-501. PubMed ID: 21826667
[TBL] [Abstract][Full Text] [Related]
16. Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness.
Burns DP; Murphy KH; Lucking EF; O'Halloran KD
J Physiol; 2019 Feb; 597(3):831-848. PubMed ID: 30570134
[TBL] [Abstract][Full Text] [Related]
17. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice.
Radley HG; Grounds MD
Neurobiol Dis; 2006 Aug; 23(2):387-97. PubMed ID: 16798005
[TBL] [Abstract][Full Text] [Related]
18. The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy.
Dorchies OM; Reutenauer-Patte J; Dahmane E; Ismail HM; Petermann O; Patthey- Vuadens O; Comyn SA; Gayi E; Piacenza T; Handa RJ; Décosterd LA; Ruegg UT
Am J Pathol; 2013 Feb; 182(2):485-504. PubMed ID: 23332367
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
